Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1954 of 5804
-
Could a simple sugar help people with type 1 diabetes exercise safely?
Disease control CompletedIn this study, 14 subjects with type 1 diabetes are studied in a randomized crossover study in which the subjects cycle at a fixed intensity at 60% of their maximum oxygen capacity (VO2 max) for 1 hour. Thirty minutes before each cycling test, participants consume a 200 ml bevera…
Phase: NA • Sponsor: University of Aarhus • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New alert system aims to prevent strokes in half a million heart patients
Disease control ENROLLING_BY_INVITATIONSix million Americans live with atrial fibrillation (AF), a heart rhythm abnormality that is a major risk factor for stroke and only half of those AF patients receive oral anticoagulation (AC). Within the context of an ongoing collaboration between two large learning health syste…
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for stubborn lung infection? drug trial underway
Disease control CompletedThe purpose of the study is to evaluate 1. The microbiological response and clinical efficacy of SPR720 compared with placebo in participants with nontuberculous mycobacteria pulmonary disease (NTM-PD). 2. The safety and tolerability of SPR720 in participants with NTM- PD 3. The…
Phase: PHASE2 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug BAL0891 enters human trials for Tough-to-Treat cancers
Disease control Recruiting nowThis study is a multiple cohort, multicenter, open-label Phase 1 study with dose-escalation substudies investigating intravenous (IV) BAL0891 as monotherapy, and in combination with tislelizumab or paclitaxel, to determine the safety and tolerability of increasing doses of BAL089…
Phase: PHASE1 • Sponsor: SillaJen, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Shingles shot put to the test in older HIV patients
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of the adjuvanted recombinant Zoster vaccine (RZV, or Shingrix®) in older people (\> 50 years) living with HIV (PLWH) compared to age-matched healthy adults over a 1-year period.
Phase: PHASE4 • Sponsor: Calmy Alexandra • Aim: Disease control
Last updated Jun 26, 2026 13:35 UTC
-
Robot takes the scalpel: new study tests hugo system for cancer surgeries
Disease control OngoingThis study will evaluate the safety and performance of the Medtronic Hugo™ RAS System when used for urologic RAS procedures.
Phase: NA • Sponsor: Medtronic - MITG • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Pill could help control Low-Risk bone marrow cancer
Disease control OngoingThe purpose of this study is to evaluate the safety and efficacy of oral azacitidine in participants with low to intermediate International Prognostic Scoring System Revised (IPSS-R) myelodysplastic syndrome (MDS).
Phase: PHASE2, PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Simple stretching program may counteract Diabetes-Related muscle stiffness
Disease control CompletedDiabetes is a chronic-degenerative metabolic disorder that has reached pandemic proportions mainly because of the increasing incidence and prevalence of type 2 diabetes mellitus (T2D). Diabetes hurts cardiovascular function due to chronic hyperinsulinemia and hyperglycemia, alon…
Phase: NA • Sponsor: Universita di Verona • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Cash for housing: silicon valley trial gives $1,000 monthly to homeless families
Knowledge-focused ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn about how unconditional cash payments equivalent to $1,000 for 24 months (also called 'guaranteed income') might help families experiencing homelessness and/or unstable housing in Santa Clara County, California. The main questions it a…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New hope for eczema sufferers with painful itchy nodules?
Disease control CompletedAtopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Around one-third of patients with AD have had at least 1 incidence of prurigo nodularis (PN), which is characterized by intense, persistent itchy skin and sometimes pain …
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Experimental drug aims to fix Bone-Weakening phosphate problem in rare disease
Disease control CompletedBackground: Fibrous dysplasia (FD) is a disorder that affects bone growth. Affected bone tissue is weakened, and people with FD are prone to deformities, fractures, and other problems. People with FD may also have low blood phosphate levels. This can make bones even weaker. Bett…
Phase: PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study tracks best breast cancer treatment for younger women
Knowledge-focused Recruiting nowThere is only limited data for premenopausal patients in general, as well as for differences in the use of OFS in the subgroups of pre- and perimenopausal patients, respectively. The WSG ADAPT trial data on the impact of postmenopausal status and/or use of OFS within 3-4 weeks en…
Sponsor: West German Study Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Lung cancer treatment goes home: can telemedicine replace hospital visits?
Disease control OngoingThis phase II trial tests whether subcutaneous atezolizumab can be effectively given at home with medical care provided primarily using telemedicine in patients with non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's im…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI-Powered Low-Radiation CT scans could transform emergency diagnosis
Diagnosis CompletedThe goal of this non-inferiority observational study is to assess the diagnostic performance of low-dose CT with deep learning image reconstruction (DLIR) in adult participants with acute abdominal conditions. The main research question is: • Can low-dose CT with DLIR achieve th…
Sponsor: Oslo University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Blood biopsy study aims to improve cancer detection and monitoring
Knowledge-focused Recruiting nowThis exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Omega-3-rich menus may slow loss of independence in elderly
Disease control CompletedMalnutrition has serious consequences: increased risk of falls, hospitalization and mortality. Malnutrition may accompany or aggravate another geriatric syndrome. The loss of muscle mass and function, called "sarcopenia" can itself lead to a loss of physical activity and therefor…
Phase: NA • Sponsor: Rennes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Smart testing slashes antibiotic overuse in ER lung cases
Knowledge-focused CompletedAcute respiratory infections are a common reason of attendance at emergency departments. It is also the main reason of unnecessary antibiotic prescription. Antibiotics save lives, but can also directly harm patients by causing antibiotic-associated adverse events. Antibiotic use …
Phase: NA • Sponsor: Dr Boillat-Blanco Noemie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Double hormone blockade may tackle Hard-to-Treat breast cancer
Disease control TerminatedThis is a multicenter, Phase 1b-2 study of elacestrant in combination with onapristone in patients with advanced/metastatic ER+/PgR+/HER2- breast cancer.
Phase: PHASE1, PHASE2 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug could ease stubborn shoulder pain
Symptom relief CompletedThe purpose of this study was to investigate the efficacy and safety of secukinumab subcutaneously (s.c.) compared to placebo in adult patients with moderate to severe rotator cuff tendinopathy and failure to conventional therapy.
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Can short videos save lives? new study tests messages for suicidal veterans
Knowledge-focused CompletedThe risk for suicide increases by nearly 50% in the first year that service members transition from the military to civilian life underscoring the need for effective strategies to facilitate help seeking among Veterans vulnerable to self-directed violence. Yet despite a great nee…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC